Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
about
Prenatal nutritional deficiency and risk of adult schizophreniaHyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine modelElevated homocysteine levels in type 2 diabetes induce constitutive neutrophil extracellular traps.Homocysteine inhibits inactivation of factor Va by activated protein C.cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period.Total homocysteine and cardiovascular disease.Molecular targeting of proteins by L-homocysteine: mechanistic implications for vascular disease.Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma.Homocysteine: an emergent cardiovascular risk factor?Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteineRoles of homocysteine in cell metabolism: old and new functions.The importance of hyperhomocysteinemia as a risk factor for diseases: an overview.Hyperhomocysteinemia as a risk factor for venous thrombosis.Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.Homocysteine and occlusive arterial disease.Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis?Formation of factor Va by atherosclerotic rabbit aorta mediates factor Xa-catalyzed prothrombin activationHomocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptorAdverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogenDoes nutrition have a role in peripheral vascular disease?Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiographyHyperhomocysteinemia and lower extremity wounds.Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.Hyperhomocysteinemia in Greyhounds and its Association with Hypofolatemia and Other Clinicopathologic Variables.Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging.Elevated plasma homocysteine levels in chronic periodontitis: a hospital-based case-control study.Priming effect of homocysteine on inducible vascular cell adhesion molecule-1 expression in endothelial cells.Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells.Hyperhomocysteinemia and venous thrombosis.Homocysteine decreases endothelin-1 production by cultured human endothelial cells.Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine.Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition.The effects of oral vitamin supplementation on cardiovascular risk factors.Assessment of a possible link between hyperhomocysteinemia and hyperuricemia.Characterization of the stress-inducing effects of homocysteine.Effect of homocysteine on arachidonic acid release in human platelets.
P2860
Q24643484-9C1EABC6-CFF0-4FAB-AB8C-91A65CFC1CBEQ28360470-F8933031-35AF-4AB6-A031-52CCCF882EA7Q30827538-E30FF3FB-EB6E-4C6D-849C-6183DCDBAF2BQ31574546-2DA6FD86-B4C0-4CD4-ABDE-1F354F38AF46Q33406017-E5D67195-448C-4FB0-A4AB-91325AA21550Q33785883-3CC7AF8C-3376-4923-9570-722D6AAFD21FQ33791523-AAC2B8A5-59A0-407F-8A9C-3391E95AE353Q33819400-A28EC485-20E6-4C57-A41C-757B0C32559FQ34039985-F151AB27-B9E7-4472-A00C-72AF098C87A6Q34213851-59E0AEDB-1B9E-4535-8ABA-DDF3A0FE5004Q34308857-802DFB96-48CB-430C-929B-18BE2C07D04BQ34395792-F4CE43EB-5FC5-4C95-9551-F47676EED9F6Q34395800-AA330F5B-B86B-4F45-AA35-A1F8438C826EQ34395823-6C4364B9-CBA1-442F-A997-6C6392B88180Q34703668-3D62839E-4835-4190-91CC-210C1D1E285BQ35055199-0AB0435B-BBCC-46AB-8988-C6351E7AF06AQ35542199-3BEE3E4A-61BA-4B96-BBD4-54C9C5EC0411Q35590221-22D246C7-B344-4B30-BCC3-253826E70497Q35612116-D8B60E55-DCFB-4D02-819A-16CAAB2B0E8FQ35824103-CA1ED708-B452-4819-BA3D-09FC5ABF3F04Q36392251-F55929BA-3512-4F26-86A1-ABF89809A7FCQ36449909-59FA106F-5C0A-4CBC-B58C-8EF4BEAC233AQ37256090-A91CA274-AF96-499E-9BA6-14F015F9D6E5Q37271062-FE114739-53AA-4E07-A566-EA92003EE041Q37356860-22799D05-5B1D-4382-8180-F066C9BF0DEAQ37601899-AF41A382-8ECE-4006-98D4-24FE029130FBQ38027777-92F6D8ED-94B2-4D5D-A9F8-6C668C722F81Q38191275-6A1010DC-82FD-43D0-AA78-8EFE4FC3FAC9Q38693296-560E7349-80D2-4076-833F-3B4BC62D27AFQ39839044-B3542DF4-82AA-458D-AA25-95E7853F3831Q39992691-B6F7C5D6-70AA-4E99-832B-918D676BC831Q40304955-A82306DE-9EC0-4817-AC88-96C515322598Q40425156-F283ECEF-8F4A-4CF9-845E-FFE25AF5DD03Q40941876-5152690F-B328-43D7-BCB2-82349EAE6C6BQ41041293-C78D5BEC-3D71-4A74-8C00-4015B823684CQ41208237-E380249A-A97D-4FCC-B650-9563A1142A89Q41486362-BFCB393A-2E8C-499B-88AC-2D1A4152D67EQ41486934-64303B82-17C4-4DB9-9A8A-11DF54CEEB09Q42159238-62D30097-1835-4BAE-8911-9C4125B66CE5Q42520120-D82D8ED8-C35D-4142-AF3C-394C4E2ECE01
P2860
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Activation of endogenous facto ...... ar endothelial cell activator.
@en
type
label
Activation of endogenous facto ...... ar endothelial cell activator.
@en
prefLabel
Activation of endogenous facto ...... ar endothelial cell activator.
@en
P2860
P356
P1476
Activation of endogenous facto ...... ar endothelial cell activator.
@en
P2093
P2860
P304
P356
10.1172/JCI112519
P407
P577
1986-06-01T00:00:00Z